Stay updated on 4D-110 Dose Escalation in Choroideremia Clinical Trial

Sign up to get notified when there's something new on the 4D-110 Dose Escalation in Choroideremia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the 4D-110 Dose Escalation in Choroideremia Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    9 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change likely indicates an update or revision in the estimated primary completion date of the medical study related to the Phase 1 clinical trial for the intravitreal 4D-110 gene therapy in patients with Choroideremia.
    Difference
    0.1%
    Check dated 2024-05-11T17:05:17.000Z thumbnail image
  7. Check
    11 days ago
    Change Detected
    Summary
    The value on the webpage related to the Primary Completion Date for the study involving the Phase 1 Open-Label, Dose-Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia has been updated from an estimated date of January 19, 2023, to a new estimated date of May 9, 2024. This change likely reflects a shift in the expected timeline for the completion of this medical and healthcare-related research study.
    Difference
    2%
    Check dated 2024-05-10T08:14:53.000Z thumbnail image
  8. Check
    20 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T21:58:37.000Z thumbnail image

Stay in the know with updates to 4D-110 Dose Escalation in Choroideremia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the 4D-110 Dose Escalation in Choroideremia Clinical Trial page.